Farmaforum Partnering Day 2026

23 Sept 2026 | Madrid, Spain

PartnershipUpdated on 29 July 2026

Strategic partnerships for the clinical validation and market deployment of ELEarly Dementia

COO at ELE Biotech

Madrid, Spain

About

ELE Biotech is developing ELEarly Dementia, a blood-based platform that combines a proprietary biomarker with analytical interpretation software to identify and stratify the risk of dementia.

Designed as a first-line risk-stratification tool, ELEarly Dementia aims to support earlier patient prioritisation for further clinical evaluation. The technology is compatible with standard qPCR infrastructure already available in clinical laboratories.

We are seeking strategic partnerships with:

• Hospitals, memory clinics and clinical research groups for multicentre clinical validation and future implementation studies.

• Clinical laboratories, IVD companies and industrial partners for analytical validation, scale-up, manufacturing and regulatory development under IVDR.

• Distributors and market-access partners for future commercial deployment in Spain and international markets.

• Pharmaceutical and healthcare organisations interested in early patient stratification and more efficient diagnostic pathways.

We are open to discussing collaborative studies, pilot projects, co-development, industrialisation and future commercial partnerships.

Similar opportunities